De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening

BACKGROUND: New cervical cancer screening guidelines recommend primary human papillomavirus (HPV) testing for women age 30–65 years. Healthcare organizations are preparing to de-implement the previous recommended strategies of Pap testing or co-testing (Pap plus HPV test) and substitute primary HPV...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Erin E., Munoz-Plaza, Corrine, Altman, Danielle E., Hsu, Chunyi, Cannizzaro, Nancy T., Ngo-Metzger, Quyen, Wride, Patricia, Gould, Michael K., Mittman, Brian S., Hodeib, Melissa, Tewari, Krishnansu S., Ajamian, Lena H., Eskander, Ramez N., Tewari, Devansu, Chao, Chun R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461958/
https://www.ncbi.nlm.nih.gov/pubmed/34556189
http://dx.doi.org/10.1186/s43058-021-00211-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461958/
https://www.ncbi.nlm.nih.gov/pubmed/34556189
http://dx.doi.org/10.1186/s43058-021-00211-z

Ejemplares similares